The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2

Introduction: Poor glycemic control, assessed by higher glycated hemoglobin (HbA1c) levels, is associated with greater risk of diabetic complications. Aim: The aim of this study was to assess the association of triglyceride - to - HDL cholesterol (TG/HDL-C) ratio and triglyceride glucose (TyG) index with HbA1c and to evaluate their potential role as predictors of glycemic control in patients with diabetes mellitus type 2 (DM2). Patients and methods: This cross-sectional study was conducted in Health Center Banovici and included a total of 113 patients with DM2 classified according to their HbA1c values in two groups: DM2 HbA1c <7% - DM2 patients with good glycemic control (n=39) and DM2 HbA1c ≥7% - DM2 patients with poor glycemic control (n=74). Anthropometric, biochemical parameters and blood pressure values were measured, while TG/HDL-C ratio and TyG index were calculated. Results: TG/HDL-C ratio and TyG index were significantly higher in DM2 HbA1c≥7% compared to DM2 HbA1c<7% group (p=0.003 and p<0.001; respectively). Both TG/HDL-C ratio and TyG index were positively associated with HbA1c levels (Rho=0.29; p=0.002; Rho=0.37; p<0.001; respectively). In linear regression analysis TG/HDL-C ratio and BMI, and also TyG index and BMI were significantly independently associated with HbA1c even after controlling for age, gender, diabetes duration and smoking. When we stratified patients according to BMI values, independent association between TG/HDL-C ratio and HbA1c remained significant only in normal weight subjects (OR 0.21; 95%CI: 0.05-0.37; β=0.65; p=0.017), while independent association between TyG index and HbA1c remained significant only in overweight and obese subjects (OR 0.063; 95%CI: 0.01- 0.12; β=0.24; p =0.027). Conclusion: TG/HDL-C ratio might be a useful predictor of glycemic control in normal weight, and TyG index in overweight and obese patients with DM2.

[1]  E. Hameed.  TyG index a promising biomarker for glycemic control in type 2 Diabetes Mellitus. , 2019, Diabetes & metabolic syndrome.

[2]  M. Rasouli,et al.  Calculation of LDL‐Cholesterol vs. Direct Homogenous Assay , 2017, Journal of clinical laboratory analysis.

[3]  A. Alsabaani,et al.  Factors Associated with Long-Term Control of Type 2 Diabetes Mellitus , 2016 .

[4]  Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes , 2016, Lipids in Health and Disease.

[5]  W. Masson,et al.  Association between triglyceride/HDL cholesterol ratio and carotid atherosclerosis in postmenopausal middle-aged women , 2016 .

[6]  Y. Yılmaz,et al.  Is triglyceride/HDL ratio a reliable screening test for assessment of atherosclerotic risk in patients with chronic inflammatory disease? , 2016, Northern clinics of Istanbul.

[7]  W. Liu,et al.  Association between Triglyceride to HDL-C Ratio (TG/HDL-C) and Insulin Resistance in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus , 2016, PloS one.

[8]  S. Martin,et al.  Triglycerides to high-density lipoprotein–cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes , 2016, Current opinion in endocrinology, diabetes, and obesity.

[9]  L. Hsu,et al.  Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals , 2016, PloS one.

[10]  M. Banach,et al.  Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study. , 2015, Atherosclerosis.

[11]  F. Ismail-Beigi,et al.  Triglyceride High-Density Lipoprotein Ratios Predict Glycemia-Lowering in Response to Insulin Sensitizing Drugs in Type 2 Diabetes: A Post Hoc Analysis of the BARI 2D , 2015, Journal of diabetes research.

[12]  R. Maranhão,et al.  Effects of glycemic control upon serum lipids and lipid transfers to HDL in patients with type 2 diabetes mellitus: novel findings in unesterified cholesterol status. , 2015, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[13]  Xuefeng Yu,et al.  O R I G I N a L I N V E S T I G a T I O N Open Access , 2022 .

[14]  L. Cheskin,et al.  Triglyceride/HDL Ratio as a Screening Tool for Predicting Success at Reducing Anti-Diabetic Medications Following Weight Loss , 2013, PloS one.

[15]  P. Barter,et al.  The emerging role of HDL in glucose metabolism , 2012, Nature Reviews Endocrinology.

[16]  S. Shabana.  Can HbA1c act as a surrogate marker for cardiovascular risk , 2012 .

[17]  G. Reaven,et al.  Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterol. , 2011, Metabolism: clinical and experimental.

[18]  A. González-Chávez,et al.  Relación triglicéridos/colesterol-HDL elevada y resistencia a la insulina , 2011 .

[19]  A. González-Chávez,et al.  Elevated triglycerides/HDL-cholesterol ratio associated with insulin resistance. , 2011, Cirugia y cirujanos.

[20]  M. Rodríguez-Moran,et al.  The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. , 2010, The Journal of clinical endocrinology and metabolism.

[21]  M. Rodríguez-Moran,et al.  The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. , 2008, Metabolic syndrome and related disorders.

[22]  R. Krauss,et al.  Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? , 2005, The American journal of cardiology.

[23]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[24]  Neil R. Powe,et al.  Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.

[25]  P. Wilson,et al.  Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. , 2004, Diabetes care.

[26]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Tracey McLaughlin,et al.  Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant , 2003, Annals of Internal Medicine.

[28]  J. Frohlich,et al.  The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). , 2001, Clinical biochemistry.

[29]  F. Nuttall,et al.  Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus. , 1998, Archives of internal medicine.

[30]  A. Chait,et al.  Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation. , 1979, The Journal of clinical investigation.